Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 5|pp. 7499–7516
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
Back to articleFigure 3(3 of 6)
100%
Figure 3
Figure 3.GSEA of BDKRB2 in pan-glioma (A, B) and glioblastoma (C, D), and GSEA plots for EMT enrichment according to BDKRB2 expression in pan-glioma (E, F) and glioblastoma (G, H).